Description:

NCT00655876 F1: Radiation Therapy Oncology Group Phase III Esophagus Followup Form Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2AA3D242-F366-3171-E044-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2AA3D242-F366-3171-E044-0003BA3F9857
Keywords:
  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 7/8/15 7/8/15 -
  5. 2/6/19 2/6/19 -
  6. 2/6/19 2/6/19 -
Copyright Holder:
NCI
Uploaded on:

February 6, 2019

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

NCT00655876 F1: Radiation Therapy Oncology Group Phase III Esophagus Followup Form

No Instruction available.

  1. StudyEvent: F1: Radiation Therapy Oncology Group Phase III Esophagus Followup Form
    1. No Instruction available.
RTOG clinical trial administrative data
AMENDED DATA
Patient status
Vital Status
Primary Cause of Death
Performance Status (Zubrod)
Kg
Extent of Dysphagia
Oral alimentation
Nasogastric tube feeding
Ostomy feeding
Intravenous hyperalimentation
Other
Disease Assessment
Has the patient had a documented clinical assessment for this cancer?
Primary Tumor
Regional lymph nodes
Method of Evaluation
Distant metastasis including distant nodes
Second primary
Disease Events
Event (If no tumor events, code 00 in first box.)
Method of Evaluation
New Primary
Has a new primary cancer or MDS been diagnosed that has not been previously reported?
Site(s) of new primary
Non-Protocol Therapy Type
Report All Continuing Or New Adverse Events
CTC AE Term
CTC Adverse Event Attribution (Attribution to Protocol Treatment See protocol sections 6 & 7 for definition of "protocol treatment")
Has an AdEERS been filed
Was this SAE per NCI definitions
Is there a reasonable possibility that the event may have been caused by the investigational agent
Action taken regarding study therapy
Treatment required
Present Status
Report All Continuing Or New Adverse Events
New or continuing adverse events
CTC AE Term
CTC Adverse Event Attribution (Attribution to Protocol Treatment See protocol sections 6 & 7 for definition of "protocol treatment")
Has an AdEERS been filed
Was this SAE per NCI definitions
Is there a reasonable possibility that the event may have been caused by the investigational agent
Action taken regarding study therapy
Treatment required
Present Status
Footer

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial